Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bullish stance on Moderna (NASDAQ:MRNA), with 63% of investors opening trades with bullish expectations and 36% with bearish. The whale has been targeting a price range from $100.0 to $180.0 for Moderna over the last 3 months. The price of MRNA is currently down -2.32% at $111.3. RSI indicators suggest that the stock may be approaching oversold. Moderna's next earnings are expected to be released in 1 day.
August 04, 2023 | 11:29 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
A whale investor has taken a bullish stance on Moderna, with the majority of investors opening trades with bullish expectations. The stock price is currently down, and RSI indicators suggest it may be approaching oversold.
The bullish stance taken by a whale investor, along with the majority of investors opening trades with bullish expectations, suggests a positive outlook for Moderna. However, the current decrease in stock price and potential oversold status could indicate short-term volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100